EP3318259 - Bibliographic data
COMPOSITION PHARMACEUTIQUE STABLE POUR ADMINISTRATION PAR VOIE ORALE
Last update | 15/06/2025 |
---|---|
Legal status | Brevet délivré |
Origin | Euro-PCT |
(73) Holder |
ASTELLAS PHARMA INC. 5-1, Nihonbashi-Honcho 2-chome
103-8411 s
CHUO-KU, TOKYO
Japon
|
---|---|
(72) Inventors |
Masakazu MIYAZAKI c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411
Japon
Ryohei ISHIBA c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411
Japon
Yuki TAKAISHI c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411
Japon
Fumiaki UEJO c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411
Japon
|
(74) Agent |
Mail recipient
VALIPAT Avenue Louise 54
1050
BRUSSELS
Belgique
|
(21) Request number | EP16821324.7 |
---|---|
(22) Request date | 01/07/2016 |
(11) Publication number | EP3318259 |
---|---|
Publication date | 11/01/2023 |
(54) Title of the invention | COMPOSITION PHARMACEUTIQUE STABLE POUR ADMINISTRATION PAR VOIE ORALE |
---|---|
(51) International classification | A61K 31/497, A61K 9/20, A61K 47/10, A61K 47/26, A61P 35/00 |
International classification (before reform) | None |
Claimed priority |
(31) Number: 2015134817 |
---|---|
Initial application | None |
Divisional application | EP23150843.3 /EP4230208 None |
Expected annuity | Annuity: 10 - Amount: 195 € - Due date 31/07/2025 |
---|---|
Last annuity | Annuity: 9 - Payment date 21/06/2024 |
Publication | None |
---|---|
History | Publication de la délivrance du brevet européen - Legal date 11/01/2023 Constitution de mandataire pour un dossier - Legal date 30/03/2023 Mise à jour des données du registre en ligne - Legal date 04/04/2025 |